| AASLD

A Letter from AASLD President Saul J. Karpen: Elevating Science and Hope This Rare Disease Month

Read more about A Letter from AASLD President Saul J. Karpen: Elevating Science and Hope This Rare Disease Month

As we recognize Rare Disease Month this February and Rare Disease Day on February 28, I’m reminded that in pediatric hepatology...

Noninvasive Liver Test Performs as Well as Biopsy in Predicting Liver Outcomes in MASLD

Read more about Noninvasive Liver Test Performs as Well as Biopsy in Predicting Liver Outcomes in MASLD

ALEXANDRIA, Virginia — A new study in HEPATOLOGY, the premier journal in the field of liver disease, reports that a noninvasive...

AASLD Launches Clinical Informatics and Digital Health Special Interest Group to Advance Innovation in Hepatology

Read more about AASLD Launches Clinical Informatics and Digital Health Special Interest Group to Advance Innovation in Hepatology

Alexandria, VA — The American Association for the Study of Liver Diseases (AASLD) announced the launch of its new Clinical...

Liver Care for Frontline Clinicians (Denver)

Read more about Liver Care for Frontline Clinicians (Denver)

Please note this event takes place in Denver and is scheduled in Mountain Time.

Organized by: Past President, W. Ray Kim and...

2027 AASLD Leadership Nominations

Read more about 2027 AASLD Leadership Nominations

AASLD is committed to a new year of elevated opportunities, expanded impact, and continued leadership in hepatology. Through our advocacy, expertise, and commitment to innovation, we are shaping the future of hepatology and building on the momentum created by our dedicated leaders.

Active AASLD members are invited to submit a self or peer nomination for the 2027 Leadership Nominations cycle by March 1 at 11:59 p.m. EDT. Completed nomination applications will be due by March 18 at 11:59 p.m. EDT.